Themasap Khan
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
Luma Group thesis
Whitepapers April 23, 2026 Rebuilding a Brittle Market: Regulatory Reform and the Return of Innovation in Osteoporosis Osteoporosis, a condition where bones become weak and brittle due to loss of bone density, is often seen as a natural part of aging, but it is more accurately a chronic disease caused by disrupted bone remodeling. 10 million Americans over age 50 have osteoporosis, and another 43 million have low bone mass.[1] Despite this, many patients remain undiagnosed and untreated. While existing therapies can reduce fracture risk, they do not provide a safe, effective long-term solution
Sector and stage focus
- Series A: Consumer Health, BioTech, Health IT, Health & Hospital Services, Digital Health
- Seed: BioTech, Consumer Health, Health IT, Digital Health, Health & Hospital Services
- general: San Francisco Bay Area
Is Themasap Khan a fit for your round?
Upload your pitch deck and see whether Themasap Khan appears in your top 20 matches.
Find investors for your deck